skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Hematology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Obinutuzumab (GA101) compared to rituximab significantly enhances cell death and antibody‐dependent cytotoxicity and improves overall survival against CD20+ rituximab‐sensitive/‐resistant Burkitt lymphoma (BL) and precursor B‐acute lymphoblastic leukaemia (pre‐B‐ALL): potential targeted therapy in patients with poor risk CD20+ BL and pre‐B‐ALL
Obinutuzumab (GA101) compared to rituximab significantly enhances cell death and antibody‐dependent cytotoxicity and improves overall survival against CD20+ rituximab‐sensitive/‐resistant Burkitt lymphoma (BL) and precursor B‐acute lymphoblastic leukaemia (pre‐B‐ALL): potential targeted therapy in patients with poor risk CD20+ BL and pre‐B‐ALL
Material Type:
Artigo 		Adicionar ao Meu Espaço

Obinutuzumab (GA101) compared to rituximab significantly enhances cell death and antibody‐dependent cytotoxicity and improves overall survival against CD20+ rituximab‐sensitive/‐resistant Burkitt lymphoma (BL) and precursor B‐acute lymphoblastic leukaemia (pre‐B‐ALL): potential targeted therapy in patients with poor risk CD20+ BL and pre‐B‐ALL

Awasthi, Aradhana ; Ayello, Janet ; Van de Ven, Carmella ; Elmacken, Mona ; Sabulski, Anthony ; Barth, Matthew J. ; Czuczman, Myron S. ; Islam, Humayun ; Klein, Christian ; Cairo, Mitchell S.

British journal of haematology, 2015-12, Vol.171 (5), p.763-775 [Periódico revisado por pares]

England

Texto completo disponível

Citações Citado por
2
ISTH guidelines for treatment of thrombotic thrombocytopenic purpura
ISTH guidelines for treatment of thrombotic thrombocytopenic purpura
Material Type:
Artigo 		Adicionar ao Meu Espaço

ISTH guidelines for treatment of thrombotic thrombocytopenic purpura

Zheng, X. Long ; Vesely, Sara K. ; Cataland, Spero R. ; Coppo, Paul ; Geldziler, Brian ; Iorio, Alfonso ; Matsumoto, Masanori ; Mustafa, Reem A. ; Pai, Menaka ; Rock, Gail ; Russell, Lene ; Tarawneh, Rawan ; Valdes, Julie ; Peyvandi, Flora

Journal of thrombosis and haemostasis, 2020-10, Vol.18 (10), p.2496-2502 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
3
B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment
B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment
Material Type:
Artigo 		Adicionar ao Meu Espaço

B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment

Fluge, Øystein ; Risa, Kristin ; Lunde, Sigrid ; Alme, Kine ; Rekeland, Ingrid Gurvin ; Sapkota, Dipak ; Kristoffersen, Einar Kleboe ; Sørland, Kari ; Bruland, Ove ; Dahl, Olav ; Mella, Olav van der Feltz-Cornelis, Christina

PloS one, 2015-07, Vol.10 (7), p.e0129898 [Periódico revisado por pares]

United States: Public Library of Science

Texto completo disponível

Citações Citado por
4
Optimization of rituximab for the treatment of DLBCL: increasing the dose for elderly male patients
Optimization of rituximab for the treatment of DLBCL: increasing the dose for elderly male patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Optimization of rituximab for the treatment of DLBCL: increasing the dose for elderly male patients

Pfreundschuh, Michael ; Murawski, Niels ; Zeynalova, Samira ; Ziepert, Marita ; Loeffler, M. ; Hänel, Matthias ; Dierlamm, Judith ; Keller, Ulrich ; Dreyling, Martin ; Truemper, Lorenz ; Frickhofen, Norbert ; Hünerlitürkoglu, Ali‐Nuri ; Schmitz, Norbert ; Pöschel, Viola ; Rixecker, Tanja ; Berdel, Christian ; Rübe, Christian ; Held, Gerhard ; Zwick, Carsten

British journal of haematology, 2017-11, Vol.179 (3), p.410-420 [Periódico revisado por pares]

England: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
5
A tale of two antibodies: obinutuzumab versus rituximab
A tale of two antibodies: obinutuzumab versus rituximab
Material Type:
Artigo 		Adicionar ao Meu Espaço

A tale of two antibodies: obinutuzumab versus rituximab

Freeman, Ciara L. ; Sehn, Laurie H.

British journal of haematology, 2018-07, Vol.182 (1), p.29-45 [Periódico revisado por pares]

England: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
6
Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma
Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma

Tilly, Hervé ; Morschhauser, Franck ; Sehn, Laurie H ; Friedberg, Jonathan W ; Trněný, Marek ; Sharman, Jeff P ; Herbaux, Charles ; Burke, John M ; Matasar, Matthew ; Rai, Shinya ; Izutsu, Koji ; Mehta-Shah, Neha ; Oberic, Lucie ; Chauchet, Adrien ; Jurczak, Wojciech ; Song, Yuqin ; Greil, Richard ; Mykhalska, Larysa ; Bergua-Burgués, Juan M ; Cheung, Matthew C ; Pinto, Antonio ; Shin, Ho-Jin ; Hapgood, Greg ; Munhoz, Eduardo ; Abrisqueta, Pau ; Gau, Jyh-Pyng ; Hirata, Jamie ; Jiang, Yanwen ; Yan, Mark ; Lee, Calvin ; Flowers, Christopher R ; Salles, Gilles

The New England journal of medicine, 2022-01, Vol.386 (4), p.351-363 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
7
Venetoclax–Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia
Venetoclax–Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Venetoclax–Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia

Seymour, John F ; Kipps, Thomas J ; Eichhorst, Barbara ; Hillmen, Peter ; D’Rozario, James ; Assouline, Sarit ; Owen, Carolyn ; Gerecitano, John ; Robak, Tadeusz ; De la Serna, Javier ; Jaeger, Ulrich ; Cartron, Guillaume ; Montillo, Marco ; Humerickhouse, Rod ; Punnoose, Elizabeth A ; Li, Yan ; Boyer, Michelle ; Humphrey, Kathryn ; Mobasher, Mehrdad ; Kater, Arnon P

The New England journal of medicine, 2018-03, Vol.378 (12), p.1107-1120 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
8
Rituximab‐induced acute and delayed serum sickness in thrombotic thrombocytopenic purpura: the role of anti‐rituximab antibodies
Rituximab‐induced acute and delayed serum sickness in thrombotic thrombocytopenic purpura: the role of anti‐rituximab antibodies
Material Type:
Artigo 		Adicionar ao Meu Espaço

Rituximab‐induced acute and delayed serum sickness in thrombotic thrombocytopenic purpura: the role of anti‐rituximab antibodies

Vendramin, Chiara ; Thomas, Mari ; Westwood, John‐Paul ; McGuckin, Siobhan ; Scully, Marie

British journal of haematology, 2019-03, Vol.184 (5), p.858-861 [Periódico revisado por pares]

England: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
9
Rituximab exposure is influenced by baseline metabolic tumor volume and predicts outcome of DLBCL patients: a Lymphoma Study Association report
Rituximab exposure is influenced by baseline metabolic tumor volume and predicts outcome of DLBCL patients: a Lymphoma Study Association report
Material Type:
Artigo 		Adicionar ao Meu Espaço

Rituximab exposure is influenced by baseline metabolic tumor volume and predicts outcome of DLBCL patients: a Lymphoma Study Association report

Tout, Mira ; Casasnovas, Olivier ; Meignan, Michel ; Lamy, Thierry ; Morschhauser, Franck ; Salles, Gilles ; Gyan, Emmanuel ; Haioun, Corinne ; Mercier, Mélanie ; Feugier, Pierre ; Boussetta, Sami ; Paintaud, Gilles ; Ternant, David ; Cartron, Guillaume

Blood, 2017-05, Vol.129 (19), p.2616-2623 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
10
The SUMOylation inhibitor subasumstat potentiates rituximab activity by IFN1-dependent macrophage and NK cell stimulation
The SUMOylation inhibitor subasumstat potentiates rituximab activity by IFN1-dependent macrophage and NK cell stimulation
Material Type:
Artigo 		Adicionar ao Meu Espaço

The SUMOylation inhibitor subasumstat potentiates rituximab activity by IFN1-dependent macrophage and NK cell stimulation

Nakamura, Akito ; Grossman, Stephen ; Song, Keli ; Xega, Kristina ; Zhang, Yuhong ; Cvet, Donna ; Berger, Allison ; Shapiro, Gary ; Huszar, Dennis

Blood, 2022-05, Vol.139 (18), p.2770-2781 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (5.277)
  2. Revistas revisadas por pares (5.211)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (5.396)
  2. Book Chapters  (11)
  3. Anais de Congresso  (3)
  4. Newsletter Articles  (3)
  5. Web Resources  (1)
  6. Livros  (1)
  7. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de2001  (46)
  2. 2001Até2005  (516)
  3. 2006Até2010  (1.092)
  4. 2011Até2016  (1.649)
  5. Após 2016  (2.116)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (5.404)
  2. Japonês  (673)
  3. Italiano  (12)
  4. Português  (9)
  5. Alemão  (8)
  6. Norueguês  (8)
  7. Francês  (5)
  8. Espanhol  (4)
  9. Russo  (1)
  10. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.